BioCentury
ARTICLE | Financial News

Arvinas raises $55M series C

April 6, 2018 5:07 PM UTC

Protein degradation company Arvinas LLC (New Haven, Conn.) raised $55 million in a series C round on April 4 led by new investor Nextech Invest. New investors Deerfield Management, Hillhouse Capital and Sirona Capital also participated alongside existing investors Canaan Partners, 5AM Ventures, RA Capital, OrbiMed and New Leaf Venture Partners.

Arvinas CFO Sean Cassidy told BioCentury the round will provide the company with about two years of runway...

BCIQ Company Profiles

Arvinas Inc.